JP2017500030A5 - - Google Patents

Download PDF

Info

Publication number
JP2017500030A5
JP2017500030A5 JP2016538531A JP2016538531A JP2017500030A5 JP 2017500030 A5 JP2017500030 A5 JP 2017500030A5 JP 2016538531 A JP2016538531 A JP 2016538531A JP 2016538531 A JP2016538531 A JP 2016538531A JP 2017500030 A5 JP2017500030 A5 JP 2017500030A5
Authority
JP
Japan
Prior art keywords
acid sequence
seq
set forth
nucleic acid
sequence set
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016538531A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017500030A (ja
JP7078350B2 (ja
Filing date
Publication date
Priority claimed from PCT/US2013/075137 external-priority patent/WO2014093894A2/en
Application filed filed Critical
Priority claimed from PCT/US2014/070188 external-priority patent/WO2015089492A2/en
Publication of JP2017500030A publication Critical patent/JP2017500030A/ja
Publication of JP2017500030A5 publication Critical patent/JP2017500030A5/ja
Priority to JP2021108614A priority Critical patent/JP2021166534A/ja
Application granted granted Critical
Publication of JP7078350B2 publication Critical patent/JP7078350B2/ja
Priority to JP2023108341A priority patent/JP2023138998A/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016538531A 2012-12-13 2014-12-13 Ｄｎａ抗体構築物及びその使用方法 Expired - Fee Related JP7078350B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2021108614A JP2021166534A (ja) 2013-12-13 2021-06-30 Ｄｎａ抗体構築物及びその使用方法
JP2023108341A JP2023138998A (ja) 2012-12-13 2023-06-30 Ｄｎａ抗体構築物及びその使用方法

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201361896646P 2013-10-28 2013-10-28
PCT/US2013/075137 WO2014093894A2 (en) 2012-12-13 2013-12-13 Dna antibody constructs and method of using same
USPCT/US2013/075137 2013-12-13
PCT/US2014/070188 WO2015089492A2 (en) 2013-12-13 2014-12-13 Dna antibody constructs and method of using same

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2020035240A Division JP2020108381A (ja) 2012-12-13 2020-03-02 Ｄｎａ抗体構築物及びその使用方法
JP2021108614A Division JP2021166534A (ja) 2012-12-13 2021-06-30 Ｄｎａ抗体構築物及びその使用方法

Publications (3)

Publication Number Publication Date
JP2017500030A JP2017500030A (ja) 2017-01-05
JP2017500030A5 true JP2017500030A5 (Direct) 2018-01-25
JP7078350B2 JP7078350B2 (ja) 2022-05-31

Family

ID=81845563

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016538531A Expired - Fee Related JP7078350B2 (ja) 2012-12-13 2014-12-13 Ｄｎａ抗体構築物及びその使用方法

Country Status (1)

Country Link
JP (1) JP7078350B2 (Direct)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2015007575A (es) * 2012-12-13 2016-03-15 Univ Pennsylvania Construcciones de anticuerpos de adn y metodo para utilizarlas.
GB201704417D0 (en) * 2017-03-20 2017-05-03 Univ Copenhagen Improved li vaccine adjuvant

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7498024B2 (en) 2003-06-03 2009-03-03 Cell Genesys, Inc. Compositions and methods for enhanced expression of immunoglobulins from a single vector using a peptide cleavage site
EP1765846A4 (en) * 2004-07-13 2010-02-17 Cell Genesys Inc AAV VECTOR COMPOSITIONS AND ITS USE IN PROCESSES FOR INCREASING IMMUNOGLOBULIN EXPRESSION
AU2009305113B2 (en) 2008-10-13 2015-07-16 Institute For Research In Biomedicine Dengue virus neutralizing antibodies and uses thereof

Similar Documents

Publication Publication Date Title
UA124343C2 (uk) Капсиди аденоасоційованого вірусу і спосіб його використання
MX2018010824A (es) Proteinas de union inducibles y metodos de uso.
JP2016529229A5 (Direct)
WO2015188132A8 (en) Methods of constructing amino terminal immunoglobulin fusion proteins and compositions thereof
EA201792573A1 (ru) Триспецифические связанные белки и способы их применения
JP2016053091A5 (Direct)
RU2017134456A (ru) Рекомбинантные связывающие белки и их применение
CR20230026A (es) Proteínas de fusión gdf15 y usos de estas (divisional 2018-0532)
IL288541B (en) Vaccine against rsv
JP2013107899A5 (Direct)
EA201491049A1 (ru) Противораковый слитый белок
RU2021124437A (ru) Конструкции, направленные на комплексы пептида afp/mhc, и виды их использования
HRP20231496T1 (hr) Cistein proteaza
JP2015212284A5 (Direct)
EA201200515A1 (ru) Полипептиды и их применение
JP2016501535A5 (Direct)
BR112013029409A8 (pt) produtos farmacêuticos de peptídeo melhorados para resistência à insulina
BR112015020315A2 (pt) conjugação de anticorpo-fármaco sítio-específica por glicoengenharia
RU2017114673A (ru) Слитый белок, наночастица, состоящая из множества мономеров указанного слитого белка, и их применение
JP2014510519A5 (Direct)
EA201990885A1 (ru) Композиции, содержащие короткие пептиды, полученные из pedf, и их применение
PL393578A1 (pl) Przeciwnowotworowe białko fuzyjne
NZ769391A (en) Serpin fusion polypeptides and methods of use thereof
RU2017132689A (ru) СЛИТАЯ С Fc α-ЦЕПЬ ВЫСОКОАФФИННОГО РЕЦЕПТОРА IgE
CY1117283T1 (el) Σταθερα μονομερη και ολιγομερη αμυλοειδους βητα